2-(3,5-DIMETHYLBENZOYL)BENZOIC ACID
- $189 - $1047
- Product name: 2-(3,5-DIMETHYLBENZOYL)BENZOIC ACID
- CAS: 149817-31-2
- MF: C16H14O3
- MW: 254.28
- EINECS:
- MDL Number:MFCD00429472
- Synonyms:2-(3,5-DIMETHYLBENZOYL)BENZOIC ACID;Benzoic acid, 2-(3,5-dimethylbenzoyl)-
5 prices
Selected condition:
Brand
- American Custom Chemicals Corporation
- Crysdot
- Matrix Scientific
- Rieke Metals
Package
- 500MG
- 1g
- 5g
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0088060
- Product description2-(3,5-DIMETHYLBENZOYL)BENZOIC ACID 95.00%
- Packaging500MG
- Price$785.4
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD12139818
- Product description2-(3,5-Dimethylbenzoyl)benzoicacid 97%
- Packaging5g
- Price$811
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number037908
- Product description2-(3,5-Dimethylbenzoyl)benzoic acid
- Packaging500mg
- Price$189
- Updated2021-12-16
- Buy
- ManufacturerRieke Metals
- Product numberC0214014
- Product description2-(3,5-Dimethyl-benzoyl)-benzoicacid
- Packaging5g
- Price$1047
- Updated2021-12-16
- Buy
- ManufacturerRieke Metals
- Product numberC0214014
- Product description2-(3,5-Dimethyl-benzoyl)-benzoicacid
- Packaging1g
- Price$367
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
American Custom Chemicals Corporation | CHM0088060 | 2-(3,5-DIMETHYLBENZOYL)BENZOIC ACID 95.00% | 500MG | $785.4 | 2021-12-16 | Buy |
Crysdot | CD12139818 | 2-(3,5-Dimethylbenzoyl)benzoicacid 97% | 5g | $811 | 2021-12-16 | Buy |
Matrix Scientific | 037908 | 2-(3,5-Dimethylbenzoyl)benzoic acid | 500mg | $189 | 2021-12-16 | Buy |
Rieke Metals | C0214014 | 2-(3,5-Dimethyl-benzoyl)-benzoicacid | 5g | $1047 | 2021-12-16 | Buy |
Rieke Metals | C0214014 | 2-(3,5-Dimethyl-benzoyl)-benzoicacid | 1g | $367 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|